{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:18:27Z","timestamp":1778055507125,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>N-<jats:italic toggle=\"yes\">myc<\/jats:italic> downstream-regulated gene-1 (NDRG1) is a hypoxia-inducible and differentiation-related protein and candidate biomarker in pancreatic cancer. As NDRG1 expression is lost in high-grade tumors, the effects of the differentiating histone deacetylase inhibitor trichostatin A (TSA) were examined in human pancreatic cancer cell lines representing different tumor grades.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>PANC-1 (poorly differentiated) and Capan-1 (moderately to well-differentiated) cells were treated with TSA. Effects were assessed in vitro by microscopic analysis, colorimetric assays, cell counts, real-time polymerase chain reaction, and Western blotting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Treatment of PANC-1 cells over 4 days with 0.5 \u03bcM TSA restored cellular differentiation, inhibited proliferation, and enhanced p21<jats:sup>Cip1<\/jats:sup> protein expression. Trichostatin A upregulated NDRG1 mRNA and protein levels under normoxia from day 1 and by 6-fold by day 4 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01 at all time points). After 24 hours under hypoxia, NDRG1 expression was further increased in differentiated cells (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). Favorable changes were identified in the expression of other hypoxia-regulated genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Histone deacetylase inhibitors offer a potential novel epidrug approach for pancreatic cancer by reversing the undifferentiated phenotype and allowing patients to overcome resistance and better respond to conventional cytotoxic treatments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mpa.0000000000000982","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T21:53:16Z","timestamp":1515189196000},"page":"200-207","source":"Crossref","is-referenced-by-count":20,"title":["Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein NDRG1 in Pancreatic Cancer"],"prefix":"10.1097","volume":"47","author":[{"given":"C\u00e9line","family":"Tiffon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20231016","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0002-9610(83)90149-6","article-title":"Current trends in the diagnosis and treatment of carcinoma of the pancreas","volume":"145","year":"1983","journal-title":"Am J Surg"},{"key":"bib2-20231016","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bjc.6603256","article-title":"Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer","volume":"95","year":"2006","journal-title":"Br J Cancer"},{"key":"bib3-20231016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","article-title":"Pancreatic cancer","volume":"3","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"bib4-20231016","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"bib5-20231016","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/annonc\/mdu138","article-title":"European cancer mortality predictions for the year 2014","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"key":"bib6-20231016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0960-7404(00)00041-4","article-title":"The molecular genetics of pancreatic ductal carcinoma: a review","volume":"9","year":"2000","journal-title":"Surg Oncol"},{"key":"bib7-20231016","first-page":"3711","article-title":"Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic","volume":"5","year":"1999","journal-title":"Clin Cancer Res"},{"key":"bib8-20231016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006676-200301000-00010","article-title":"Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer","volume":"26","year":"2003","journal-title":"Pancreas"},{"key":"bib9-20231016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jss.2004.02.014","article-title":"Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model","volume":"120","year":"2004","journal-title":"J Surg Res"},{"key":"bib10-20231016","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature05919","article-title":"Phenotypic plasticity and the epigenetics of human disease","volume":"447","year":"2007","journal-title":"Nature"},{"key":"bib11-20231016","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.pathol.3.121806.151442","article-title":"Epigenetic changes in cancer","volume":"4","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"bib12-20231016","first-page":"1565","article-title":"p300 gene alterations in colorectal and gastric carcinomas","volume":"12","year":"1996","journal-title":"Oncogene"},{"key":"bib13-20231016","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/35901","article-title":"Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia","volume":"391","year":"1998","journal-title":"Nature"},{"key":"bib14-20231016","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/35895","article-title":"Role of the histone deacetylase complex in acute promyelocytic leukaemia","volume":"391","year":"1998","journal-title":"Nature"},{"key":"bib15-20231016","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2217\/fon.15.171","article-title":"Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development","volume":"11","year":"2015","journal-title":"Future Oncol"},{"key":"bib16-20231016","first-page":"101","article-title":"Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature","volume":"196","year":"2008","journal-title":"J Endocrinol"},{"key":"bib17-20231016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.reprotox.2011.03.001","article-title":"Abnormal peripubertal development of the rat mammary gland following exposure in utero and during lactation to a mixture of genistein and the food contaminant vinclozolin","volume":"32","year":"2011","journal-title":"Reprod Toxicol"},{"key":"bib18-20231016","first-page":"245","article-title":"In utero and lactational exposure to vinclozolin and genistein induces genomic changes in the rat mammary gland","volume":"216","year":"2013","journal-title":"J Endocrinol"},{"key":"bib19-20231016","doi-asserted-by":"crossref","first-page":"e99800","DOI":"10.1371\/journal.pone.0099800","article-title":"Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"bib20-20231016","article-title":"Nutrients and the pancreas: an epigenetic perspective","volume":"9","year":"2017","journal-title":"Nutrients"},{"key":"bib21-20231016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/epi.11.22","article-title":"Epigenetics and lifestyle","volume":"3","year":"2011","journal-title":"Epigenomics"},{"key":"bib22-20231016","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/nm.3952","article-title":"Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma","volume":"21","year":"2015","journal-title":"Nat Med"},{"key":"bib23-20231016","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1007\/s13277-015-4216-2","article-title":"SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin","volume":"37","year":"2016","journal-title":"Tumour Biol"},{"key":"bib24-20231016","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2016.04.013","article-title":"Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer","volume":"119","year":"2016","journal-title":"Radiother Oncol"},{"key":"bib25-20231016","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bies.950170510","article-title":"Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function","volume":"17","year":"1995","journal-title":"Bioessays"},{"key":"bib26-20231016","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","year":"2007","journal-title":"Cell"},{"key":"bib27-20231016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ctrv.2005.12.006","article-title":"Histone deacetylase inhibitors: multifunctional anticancer agents","volume":"32","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"bib28-20231016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1535-6108(03)00165-X","article-title":"Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?","volume":"4","year":"2003","journal-title":"Cancer Cell"},{"key":"bib29-20231016","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3748\/wjg.v10.i18.2643","article-title":"Histone acetylation regulates p21WAF1 expression in human colon cancer cell lines","volume":"10","year":"2004","journal-title":"World J Gastroenterol"},{"key":"bib30-20231016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6750-3-11","article-title":"Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction","volume":"3","year":"2003","journal-title":"BMC Biotechnol"},{"key":"bib31-20231016","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MPA.0b013e3181c8b476","article-title":"Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells","volume":"39","year":"2010","journal-title":"Pancreas"},{"key":"bib32-20231016","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20041057","article-title":"Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3","volume":"384","year":"2004","journal-title":"Biochem J"},{"key":"bib33-20231016","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1248\/bpb.27.624","article-title":"N-myc downregulated gene 1 is a phosphorylated protein in mast cells","volume":"27","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"bib34-20231016","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1074\/mcp.M500044-MCP200","article-title":"Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis","volume":"4","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"bib35-20231016","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1158\/0008-5472.CAN-06-3197","article-title":"Lysyl oxidase mediates hypoxic control of metastasis","volume":"66","year":"2006","journal-title":"Cancer Res"},{"key":"bib36-20231016","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2001.19.16.3660","article-title":"Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma","volume":"19","year":"2001","journal-title":"J Clin Oncol"},{"key":"bib37-20231016","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ceb.2015.10.001","article-title":"Crosstalk between stem cell and cell cycle machineries","volume":"37","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"bib38-20231016","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1073\/pnas.1408638111","article-title":"Molecular ties between the cell cycle and differentiation in embryonic stem cells","volume":"111","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib39-20231016","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1038\/sj.onc.1206558","article-title":"Cell cycle regulation and neural differentiation","volume":"22","year":"2003","journal-title":"Oncogene"},{"key":"bib40-20231016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0959-437X(96)90011-8","article-title":"Cdk inhibitors in development and cancer","volume":"6","year":"1996","journal-title":"Curr Opin Genet Dev"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006676-201802000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:36:06Z","timestamp":1697427366000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201802000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000982","relation":{},"ISSN":["1536-4828","0885-3177"],"issn-type":[{"value":"1536-4828","type":"electronic"},{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}